Skip to main content
SpringerLink
Log in

Evaluation of HbA1c levels as probable diagnostic of depression symptoms in Mexican individuals with type 2 diabetes mellitus

  • Original Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Background

Depression is present in individuals with type 2 diabetes mellitus.

Objective  

We evaluated the sociodemographic, anthropometric, and clinical features of Mexican individuals with clinical depressive symptoms in order to identify predictors for depression symptoms; finally, we evaluated if HbA1c levels could be used as a probable diagnostic of depressive symptoms in individuals with type 2 diabetes mellitus.

Methods

The population studied consisted of 376 Mexicans with diabetes who were interviewed to collect information about comorbidities and habits. The evaluation of depressive symptoms was performed using the Hamilton scale. For a possible clinical association between HbA1c levels and depressive symptoms, we performed chi-square tests (χ2)/ t tests. A multivariate logistic regression model with the backward conditional method was used to identify predictors of depressive symptoms. An ROC curve was plotted to assess the possible role of HbA1c as a diagnostic predictive test of depression symptoms.

Results

A total of 42.8% (n = 161) individuals showed clinical depressive symptoms. When comparing individuals with and without depression symptoms, those with depression symptoms showed higher levels of glucose and HbA1c; additionally, gender (p = 0.04), age (p = 0.006), HbA1c (p < 0.01), and complications related to diabetes were predictive factors for clinical depressive symptoms (p < 0.01). However, HbA1c showed a low diagnostic accuracy for depressive symptoms, with an area under the ROC curve of 0.59.

Conclusions

Our findings provided evidence of the sex, age, HbA1c levels, and medical complications as predictors of clinical depressive symptoms in individuals with diabetes mellitus. Nevertheless, HbA1c levels are not useful as a diagnostic instrument for depressive symptom severity in these Mexican individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data Availability

Data is available on request.

References

  1. Pordzik J, et al. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review. Cardiovasc Diabetol. 2019;18(1):113–113.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Atlas, D.  International diabetes federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation. (2015);33(2).

  3. Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016 (ENSANUT 2016). Secretaria de Salud: Informe final de resultados. México; 2016.

    Google Scholar 

  4. Calero Bernal ML, Varela Aguilar JM. Infant-juvenile type 2 diabetes. Revista Clinica Espanola. 2018;218(7):372–81.

    Article  CAS  PubMed  Google Scholar 

  5. Hussain S, et al. Prevalence of depression among type 2 diabetes mellitus patients in India: a meta-analysis. Psychiatry Res. 2018;270:264–73.

    Article  PubMed  Google Scholar 

  6. Sughra U, Imran M. Co-morbid depression in individuals with type 2 diabetes mellitus. JPMA J Pakistan Med Assoc. 2018;68(1):109–11.

    Google Scholar 

  7. Khaledi M, et al. The prevalence of comorbid depression in patients with type 2 diabetes: an updated systematic review and meta-analysis on huge number of observational studies. Acta Diabetol. 2019;56(6):631–50.

    Article  PubMed  Google Scholar 

  8. Luca M, et al. Gut microbiota in Alzheimer’s disease, depression, and type 2 diabetes mellitus: the role of oxidative stress. Oxid Med Cell Longev. 2019;2019:4730539–4730539.

    PubMed  PubMed Central  Google Scholar 

  9. Yuan S, Larsson SC. An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study. Diabetologia. 2020;63(11):2359–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Cui R. Editorial: A Systematic Review of Depression. Curr Neuropharmacol. 2015;13(4):480.

    Article  CAS  PubMed  Google Scholar 

  11. Melin EO, et al. Depression differed by midnight cortisol secretion, alexithymia and anxiety between diabetes types: a cross sectional comparison. BMC Psychiatry. 2017;17(1):335.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Akpalu J, et al. Depression and glycemic control among type 2 diabetes patients: a cross-sectional study in a tertiary healthcare facility in Ghana. BMC Psychiatry. 2018;18(1):357–357.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Azniza MR, et al. Depression and potential risk factors among the elderly with type 2 diabetes mellitus in Kedah, Malaysia. Med J Malaysia. 2019;74(2):103–8.

    CAS  PubMed  Google Scholar 

  14. Khan P, et al. Incidence of anxiety and depression among patients with type 2 diabetes and the predicting factors. Cureus. 2019;11(3):e4254–e4254.

    PubMed  PubMed Central  Google Scholar 

  15. Ehrenthal JC, et al. Levels of personality functioning and not depression predict decline of plasma glucose concentration in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 2019;151:106–13.

    Article  CAS  PubMed  Google Scholar 

  16. Luke B. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril. 2017;107(4):868–77.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hamilton M. The Hamilton Depression Scale—accelerator or break on antidepressant drug discovery. Psychiatry. 1960;23:56–62.

    CAS  Google Scholar 

  18. National Institute for Health and Care Excellence. Depression in adults: recognition and management. London: National Institute for Health and Care Excellence; 2018.

    Google Scholar 

  19. Cortés J, Berlanga C, Bauer J. Adaptación y validación de la Escala de Depresión de Carroll en español. 1992;15(4):36–430.

    Google Scholar 

  20. Sharif S, et al. Frequency of depression in patients with type 2 diabetes mellitus and its relationship with glycemic control and diabetic microvascular complications. Cureus. 2019;11(7):e5145–e5145.

    PubMed  PubMed Central  Google Scholar 

  21. Yasui-Furukori N, et al. Coping behaviors and depressive status in individuals with type 2 diabetes mellitus. Ann Gen Psychiatry. 2019;18:11–11.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Alzahrani A, et al. Prevalence and predictors of depression, anxiety, and stress symptoms among patients with type II diabetes attending primary healthcare centers in the western region of Saudi Arabia: a cross-sectional study. Int J Ment Heal Syst. 2019;13:48–48.

    Article  Google Scholar 

  23. Park LT, Zarate CA Jr. Depression in the primary care setting. N Engl J Med. 2019;380(6):559–68.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Stickel S, et al. Neural correlates of depression in women across the reproductive lifespan - An fMRI review. J Affect Disord. 2019;246:556–70.

    Article  PubMed  Google Scholar 

  25. Mansori K, et al. Association between depression with glycemic control and its complications in type 2 diabetes. Diabetes Metab Syndr. 2019;13(2):1555–60.

    Article  PubMed  Google Scholar 

  26. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kim HJ, et al. The association of diabetes duration and glycemic control with depression in elderly men with type 2 diabetes mellitus. J Res Med Sci. 2019;24:17–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Jaworski M, et al. Severe depressive episode with psychotic symptoms and type 2 diabetes: a 2010–2017 longitudinal study. Med Sci Monit: Int Med J Exp Clin Res. 2019;25:1760–8.

    Article  Google Scholar 

  29. Afroz A, et al. Macro- and micro-vascular complications and their determinants among people with type 2 diabetes in Bangladesh. Diabetes Metab Syndr. 2019;13(5):2939–46.

    Article  PubMed  Google Scholar 

  30. Bilu C, et al. Linking type 2 diabetes mellitus, cardiac hypertrophy and depression in a diurnal animal model. Sci Rep. 2019;9(1):11865–11865.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Arambewela MH, et al. Prevalence of depression and associated factors among patients with type 2 diabetes attending the diabetic clinic at a tertiary care hospital in Sri Lanka: a descriptive study. Psychiatry J. 2019;2019:7468363–7468363.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Alajmani DSA, et al. Prevalence of undiagnosed depression in patients with type 2 diabetes. Front Endocrinol. 2019;10:259–259.

    Article  Google Scholar 

  33. Ma Y, et al. Association between cognitive vulnerability to depression - dysfunctional attitudes and glycemic control among in-patients with type 2 diabetes in a hospital in Beijing: a multivariate regression analysis. Psychol Health Med. 2018;23(2):189–97.

    Article  PubMed  Google Scholar 

  34. Li CI, et al. Competing risk analysis on visit-to-visit glucose variations and risk of depression: the Taiwan diabetes study. Diabetes Metab. 2020;46(3):223–9.

    Article  PubMed  Google Scholar 

  35. Atif M, et al. Extent and predictors of poor glycemic control among elderly Pakistani patients with type 2 diabetes mellitus: a multi-centre cross-sectional study. Medicina (Kaunas). 2019;55(1):21.

    Article  PubMed  Google Scholar 

  36. Bąk E, et al. An assessment of diabetes-dependent quality of life (ADDQoL) in women and men in Poland with type 1 and type 2 diabetes. Ann Agric Environ Med: AAEM. 2019;26(3):429–38.

    Article  PubMed  Google Scholar 

  37. Dhillon H, Nordin RB, Ramadas A. Quality of life and associated factors among primary care Asian patients with type 2 diabetes mellitus. Int J Environ Res Public Health. 2019;16(19):3561.

    Article  PubMed  PubMed Central  Google Scholar 

  38. González-Castro TB, et al. Higher risk of depression in individuals with type 2 diabetes and obesity: results of a meta-analysis. J Health Psychol. 2021;26(9):1404–19.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universidad Juárez Autónoma de Tabasco, División Académica de Ciencias de La Salud, Gregorio Méndez 2838, Villahermosa, Comalcalco, Tabasco, Mexico

    Isela Esther Juárez-Rojop, Gisselle Tovilla-Vidal & Dania Ramírez-González

  2. Universidad Juárez Autónoma de Tabasco, División Académica Multidisciplinaria de Comalcalco, Comalcalco, Tabasco, Mexico

    María Lilia López-Narváez & Carlos Alfonso Tovilla-Zárate

  3. Hospital de Alta Especialidad Gustavo A. Rovirosa Pérez, Secretaría de Salud, Villahermosa, Tabasco, Mexico

    Esther Rodríguez-Sánchez

  4. Universidad Juárez Autónoma de Tabasco, División Académica Multidisciplinaria de Jalpa de Méndez, Jalpa de Méndez, Tabasco, Mexico

    Thelma Beatriz González-Castro & Yazmín Hernández-Díaz

  5. Subdirección de Investigaciones Clínicas, Instituto Nacional de Psiquiatría Ramón de La Fuente Muñíz, Mexico City, Mexico

    Ana Fresán

Authors
  1. Isela Esther Juárez-Rojop
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gisselle Tovilla-Vidal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. María Lilia López-Narváez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos Alfonso Tovilla-Zárate
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Esther Rodríguez-Sánchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Thelma Beatriz González-Castro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ana Fresán
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dania Ramírez-González
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yazmín Hernández-Díaz
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carlos Alfonso Tovilla-Zárate.

Ethics declarations

Ethical Clearance

This study was approved by the ethics and research committee and the ethics committee of the High Specialization Regional Hospital Dr. Gustavo A. Rovirosa Pérez (00228/16).

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Juárez-Rojop, I.E., Tovilla-Vidal, G., López-Narváez, M.L. et al. Evaluation of HbA1c levels as probable diagnostic of depression symptoms in Mexican individuals with type 2 diabetes mellitus. Int J Diabetes Dev Ctries (2023). https://doi.org/10.1007/s13410-023-01232-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13410-023-01232-1

Keywords

Search

Navigation